1 Treatment efficacy: treatment responders ‐ end of treatment |
4 |
121 |
Risk Ratio (M‐H, Random, 95% CI) |
1.01 [0.78, 1.31] |
1.1 OCD |
3 |
74 |
Risk Ratio (M‐H, Random, 95% CI) |
1.13 [0.94, 1.35] |
1.2 PTSD |
1 |
47 |
Risk Ratio (M‐H, Random, 95% CI) |
0.70 [0.44, 1.10] |
2 Treatment efficacy: treatment responders ‐ 3‐12 month follow up |
3 |
91 |
Risk Ratio (M‐H, Random, 95% CI) |
0.86 [0.67, 1.09] |
2.1 OCD |
2 |
44 |
Risk Ratio (M‐H, Random, 95% CI) |
0.93 [0.71, 1.21] |
2.2 PTSD |
1 |
47 |
Risk Ratio (M‐H, Random, 95% CI) |
0.70 [0.44, 1.10] |
3 Treatment acceptability: withdrawals from treatment ‐ end of treatment |
4 |
131 |
Risk Ratio (M‐H, Random, 95% CI) |
0.90 [0.17, 4.69] |
3.1 OCD |
3 |
74 |
Risk Ratio (M‐H, Random, 95% CI) |
0.21 [0.01, 4.08] |
3.2 PTSD |
1 |
57 |
Risk Ratio (M‐H, Random, 95% CI) |
1.45 [0.46, 4.59] |
4 In remission ‐ end of treatment |
2 |
44 |
Risk Ratio (M‐H, Random, 95% CI) |
1.19 [0.66, 2.16] |
4.1 OCD |
2 |
44 |
Risk Ratio (M‐H, Random, 95% CI) |
1.19 [0.66, 2.16] |
5 In remission ‐ 3‐12 month follow up |
2 |
44 |
Risk Ratio (M‐H, Random, 95% CI) |
1.05 [0.69, 1.61] |
5.1 OCD |
2 |
44 |
Risk Ratio (M‐H, Random, 95% CI) |
1.05 [0.69, 1.61] |
6 Condition‐specific anxiety symptoms ‐ end of treatment |
4 |
131 |
Std. Mean Difference (IV, Random, 95% CI) |
0.07 [‐0.55, 0.69] |
6.1 OCD (Y‐BOCS) |
3 |
74 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.22 [‐0.70, 0.25] |
6.2 PTSD (Child PTSD Symptom Scale) |
1 |
57 |
Std. Mean Difference (IV, Random, 95% CI) |
0.70 [0.17, 1.24] |
7 Condition‐specific anxiety symptoms ‐ 3‐12 month follow up |
3 |
91 |
Std. Mean Difference (IV, Random, 95% CI) |
0.23 [‐0.32, 0.78] |
7.1 OCD (Y‐BOCS) |
2 |
44 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.06 [‐0.65, 0.54] |
7.2 PTSD (Child PTSD Symptom Scale) |
1 |
47 |
Std. Mean Difference (IV, Random, 95% CI) |
0.62 [0.03, 1.21] |
8 Co‐morbid symptoms of depression ‐ end of treatment |
3 |
114 |
Std. Mean Difference (IV, Random, 95% CI) |
0.08 [‐0.52, 0.69] |
8.1 OCD (BDI‐Y and CDI) |
2 |
57 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.24 [‐0.77, 0.28] |
8.2 PTSD (CDI) |
1 |
57 |
Std. Mean Difference (IV, Random, 95% CI) |
0.60 [0.06, 1.13] |
9 Co‐morbid symptoms of depression ‐ 3‐12 month follow up |
2 |
84 |
Std. Mean Difference (IV, Random, 95% CI) |
0.09 [‐0.56, 0.74] |
9.1 OCD (BDI‐Y) |
1 |
27 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.30 [‐1.06, 0.46] |
9.2 PTSD (CDI) |
1 |
57 |
Std. Mean Difference (IV, Random, 95% CI) |
0.37 [‐0.16, 0.89] |
10 Co‐morbid anxiety symptoms ‐ end of treatment |
3 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
10.1 OCD (MASC) |
2 |
47 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.35 [‐0.93, 0.23] |
10.2 PTSD (SCARED) |
1 |
57 |
Std. Mean Difference (IV, Random, 95% CI) |
0.80 [0.26, 1.34] |
11 Co‐morbid anxiety symptoms ‐ 3 month follow up |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
11.1 PTSD (SCARED) |
1 |
|
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |